Product Description
Beta-carotene is converted in the body to vitamin A, which is necessary for healthy eyes and skin. Beta-carotene is found in carrots; dark-green leafy vegetables, such as spinach and green leaf lettuce; sweet potatoes; broccoli; cantaloupe; and winter squash. The body converts beta-carotene into vitamin A. (Sourced from: https://www.mayoclinic.org/drugs-supplements/beta-carotene-oral-route/description/drg-20066795)
Mechanisms of Action: lipid peroxidation Inhibitor,TNF Inhibitor,Apoptosis Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Argentina | Australia | Austria | Bangladesh | Brazil | Canada | Chile | Colombia | Dominican Republic | Ecuador | Egypt | France | Hong Kong | India | Indonesia | Israel | Korea | Luxembourg | Malaysia | Malta | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|